Item Type | Name |
Academic Article
|
Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin).
|
Academic Article
|
Delayed recovery of severely "stunned" myocardium with the support of a left ventricular assist device after coronary artery bypass graft surgery.
|
Academic Article
|
Low-density lipoprotein metabolism in cerebrotendinous xanthomatosis.
|
Academic Article
|
Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant.
|
Academic Article
|
Levels of soluble cell adhesion molecules in patients with dyslipidemia.
|
Academic Article
|
Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]).
|
Academic Article
|
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.
|
Academic Article
|
Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion.
|
Academic Article
|
Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.
|
Academic Article
|
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.
|
Academic Article
|
Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
|
Academic Article
|
The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemia.
|
Academic Article
|
A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis.
|
Academic Article
|
Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Management of persons with high risk of coronary heart disease but low serum low-density lipoprotein cholesterol.
|
Academic Article
|
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
|
Academic Article
|
Fluvastatin reduces cardiac mortality in patients with coronary heart disease.
|
Academic Article
|
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
|
Academic Article
|
Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging.
|
Academic Article
|
Efficacy and safety of an extended-release formulation of fluvastatin for once-daily treatment of primary hypercholesterolemia.
|
Academic Article
|
Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.
|
Academic Article
|
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy.
|
Academic Article
|
Lipoprotein(a) and apolipoprotein changes after cardiac transplantation.
|
Academic Article
|
Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease.
|
Academic Article
|
Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome.
|
Academic Article
|
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
|
Academic Article
|
Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome.
|
Academic Article
|
Effectiveness and tolerability of adding ezetimibe to niacin-based regimens for treatment of primary hyperlipidemia.
|
Academic Article
|
Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants.
|
Academic Article
|
Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults.
|
Academic Article
|
Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease.
|
Academic Article
|
Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription.
|
Academic Article
|
Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
|
Academic Article
|
Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: the atherosclerosis risk in communities study.
|
Academic Article
|
B vitamin status and inflammatory markers.
|
Academic Article
|
Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004).
|
Academic Article
|
Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.
|
Academic Article
|
Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study).
|
Academic Article
|
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease.
|
Academic Article
|
Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery?
|
Academic Article
|
Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trial.
|
Academic Article
|
Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS).
|
Academic Article
|
Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
|
Academic Article
|
The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis.
|
Academic Article
|
Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting.
|
Academic Article
|
Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD).
|
Academic Article
|
Coronary heart disease risk, aspirin use, and apolipoprotein(a) 4399Met allele in the Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study.
|
Academic Article
|
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.
|
Academic Article
|
Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system.
|
Academic Article
|
Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease.
|
Academic Article
|
Intercellular adhesion molecule-1 G241R polymorphism predicts risk of incident ischemic stroke: Atherosclerosis Risk in Communities study.
|
Academic Article
|
Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction.
|
Academic Article
|
Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study.
|
Academic Article
|
Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.
|
Academic Article
|
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
|
Academic Article
|
Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy.
|
Academic Article
|
Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies.
|
Academic Article
|
A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study.
|
Academic Article
|
Relationship between low-density lipoprotein subclasses and asymptomatic atherosclerosis in subjects from the Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.
|
Academic Article
|
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
|
Academic Article
|
Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort.
|
Academic Article
|
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial.
|
Academic Article
|
Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial).
|
Academic Article
|
Barriers to non-HDL cholesterol goal attainment by providers.
|
Academic Article
|
Segmental analysis of carotid arterial strain using speckle-tracking.
|
Academic Article
|
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.
|
Academic Article
|
Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque.
|
Academic Article
|
Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease.
|
Academic Article
|
Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies.
|
Academic Article
|
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
|
Academic Article
|
Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study.
|
Academic Article
|
Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysis.
|
Academic Article
|
Chronic hyperglycemia and subclinical myocardial injury.
|
Academic Article
|
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects?on low-density lipoprotein-cholesterol reduction.
|
Academic Article
|
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study.
|
Academic Article
|
Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players.
|
Academic Article
|
P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant.
|
Academic Article
|
Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies.
|
Academic Article
|
Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients.
|
Academic Article
|
Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).
|
Academic Article
|
Icosapent ethyl, a pure ethyl ester of eicosapentaenoic acid: effects on circulating markers of inflammation from the MARINE and ANCHOR studies.
|
Academic Article
|
Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Effects of cyclosporine therapy on plasma lipoprotein levels.
|
Academic Article
|
Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery.
|
Academic Article
|
Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: the Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
|
Academic Article
|
APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels.
|
Academic Article
|
The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
|
Academic Article
|
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
|
Academic Article
|
Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study.
|
Academic Article
|
Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populations.
|
Academic Article
|
Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
|
Academic Article
|
Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study.
|
Academic Article
|
Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery?
|
Academic Article
|
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study.
|
Academic Article
|
Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI Study.
|
Academic Article
|
Preoperative statin therapy decreases risk of postoperative renal insufficiency.
|
Academic Article
|
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients.
|
Academic Article
|
Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.
|
Academic Article
|
The editor's roundtable: JUPITER follow-up.
|
Academic Article
|
Peripheral artery disease, biomarkers, and darapladib.
|
Academic Article
|
Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Effect of two intensive statin regimens on progression of coronary disease.
|
Academic Article
|
Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial.
|
Academic Article
|
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
|
Academic Article
|
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.
|
Academic Article
|
Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study.
|
Academic Article
|
Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
|
Academic Article
|
Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes.
|
Academic Article
|
Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study.
|
Academic Article
|
Relation of lipid gene scores to longitudinal trends in lipid levels and incidence of abnormal lipid levels among individuals of European ancestry: the Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
|
Academic Article
|
Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples.
|
Academic Article
|
Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease.
|
Academic Article
|
Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia.
|
Academic Article
|
Association between statins and infections after coronary artery bypass grafting.
|
Academic Article
|
Effects of dalcetrapib in patients with a recent acute coronary syndrome.
|
Academic Article
|
Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality.
|
Academic Article
|
Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
|
Academic Article
|
Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care.
|
Academic Article
|
Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study.
|
Academic Article
|
Increased expression of ICAM-1 in a case of accelerated coronary artery disease after heart transplantation.
|
Academic Article
|
Effect of moderate alcohol consumption on hypertriglyceridemia: a study in the fasting state.
|
Academic Article
|
Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.
|
Academic Article
|
Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.
|
Academic Article
|
A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin.
|
Academic Article
|
LPL polymorphism predicts stroke risk in men.
|
Academic Article
|
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.
|
Academic Article
|
Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study.
|
Academic Article
|
Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia.
|
Academic Article
|
Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.
|
Academic Article
|
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
|
Academic Article
|
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
|
Academic Article
|
Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.
|
Academic Article
|
An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study.
|
Academic Article
|
Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia.
|
Academic Article
|
Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
|
Academic Article
|
Pro-apoptotic low-density lipoprotein subfractions in type II diabetes.
|
Academic Article
|
Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).
|
Academic Article
|
Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
|
Academic Article
|
An annual, prospective, international study of outpatients with cardiovascular disease or risk factors: design and methods of the CardioMonitor registry.
|
Academic Article
|
How to identify patients with vulnerable plaques.
|
Academic Article
|
Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study.
|
Academic Article
|
Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
|
Academic Article
|
Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.
|
Academic Article
|
Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia.
|
Academic Article
|
Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
|
Academic Article
|
Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study.
|
Academic Article
|
A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study.
|
Academic Article
|
Safety of extended-release niacin/laropiprant in patients with dyslipidemia.
|
Academic Article
|
Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting.
|
Academic Article
|
Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN).
|
Academic Article
|
Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes.
|
Academic Article
|
Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines.
|
Academic Article
|
Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study.
|
Academic Article
|
Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (= 2 mg/L). cmb@bcm.tmc.edu.
|
Academic Article
|
Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
|
Academic Article
|
sRAGE and risk of diabetes, cardiovascular disease, and death.
|
Concept
|
Aged, 80 and over
|
Concept
|
Aged
|
Concept
|
Middle Aged
|
Academic Article
|
Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery.
|
Academic Article
|
Factors underlying regression of coronary atheroma with potent statin therapy.
|
Academic Article
|
Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study.
|
Academic Article
|
Lipoprotein-associated phospholipase A2 and venous thromboembolism: a prospective study.
|
Academic Article
|
Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes.
|
Academic Article
|
Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
|
Academic Article
|
Correlates of repeat lipid testing in patients with coronary heart disease.
|
Academic Article
|
The association of plasma lactate with incident cardiovascular outcomes: the ARIC Study.
|
Academic Article
|
Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study.
|
Academic Article
|
Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study.
|
Academic Article
|
Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
|
Academic Article
|
Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis.
|
Academic Article
|
Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study.
|
Academic Article
|
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
|
Academic Article
|
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.
|
Academic Article
|
C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
|
Academic Article
|
APOE modulates the correlation between triglycerides, cholesterol, and CHD through pleiotropy, and gene-by-gene interactions.
|
Academic Article
|
Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study.
|
Academic Article
|
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT).
|
Academic Article
|
Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.
|
Academic Article
|
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study.
|
Academic Article
|
Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.
|
Academic Article
|
Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
|
Academic Article
|
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.
|
Academic Article
|
The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals.
|
Academic Article
|
Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock.
|
Academic Article
|
Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.
|
Academic Article
|
Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).
|
Academic Article
|
Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.
|
Academic Article
|
A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.
|
Academic Article
|
Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
|
Academic Article
|
Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE registry.
|
Academic Article
|
Neck circumference is not associated with subclinical atherosclerosis in retired National Football League players.
|
Academic Article
|
B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
|
Academic Article
|
Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players.
|
Academic Article
|
Low-density lipoprotein electronegativity is a novel cardiometabolic risk factor.
|
Academic Article
|
Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage.
|
Academic Article
|
High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN.
|
Academic Article
|
Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.
|
Academic Article
|
Association of body mass index and waist circumference with subclinical atherosclerosis in retired NFL players.
|
Academic Article
|
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial.
|
Academic Article
|
Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study.
|
Academic Article
|
Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines.
|
Academic Article
|
High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study.
|
Academic Article
|
Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort.
|
Academic Article
|
Relation between playing position and coronary artery calcium scores in retired National Football League players.
|
Academic Article
|
Obesity, subclinical myocardial injury, and incident heart failure.
|
Academic Article
|
Gender disparities in evidence-based statin therapy in patients with cardiovascular disease.
|
Academic Article
|
Development of chagas cardiac manifestations among Texas blood donors.
|
Academic Article
|
High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study.
|
Academic Article
|
Inactivating mutations in NPC1L1 and protection from coronary heart disease.
|
Academic Article
|
The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.
|
Academic Article
|
Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity.
|
Academic Article
|
sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry.
|
Academic Article
|
Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.
|
Academic Article
|
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.
|
Academic Article
|
Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia.
|
Academic Article
|
Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study.
|
Academic Article
|
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
|
Academic Article
|
Recalibration of blood analytes over 25 years in the atherosclerosis risk in communities study: impact of recalibration on chronic kidney disease prevalence and incidence.
|
Academic Article
|
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria.
|
Academic Article
|
Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study).
|
Academic Article
|
Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study.
|
Academic Article
|
Implications of the Eighth Joint National Committee Guidelines for the Management of High Blood Pressure for Aging Adults: Atherosclerosis Risk in Communities Study.
|
Academic Article
|
High-Sensitivity Cardiac Troponin T and Risk of Hypertension.
|
Academic Article
|
Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
|
Academic Article
|
Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study.
|
Academic Article
|
Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk.
|
Academic Article
|
Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the Elderly.
|
Academic Article
|
Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T.
|
Academic Article
|
Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis.
|
Academic Article
|
Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study.
|
Academic Article
|
The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study.
|
Academic Article
|
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial.
|
Academic Article
|
Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
The Association of Socioeconomic Status With Subclinical Myocardial Damage, Incident Cardiovascular Events, and Mortality in the ARIC Study.
|
Academic Article
|
Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population.
|
Academic Article
|
Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
|
Academic Article
|
Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
|
Academic Article
|
Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database.
|
Academic Article
|
Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy.
|
Academic Article
|
Accuracy of the Atherosclerotic Cardiovascular Risk Equation in?a?Large?Contemporary, Multiethnic?Population.
|
Academic Article
|
Galectin-3 and Risk of Heart Failure and Death in Blacks and Whites.
|
Academic Article
|
Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance.
|
Academic Article
|
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies.
|
Academic Article
|
Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV).
|
Academic Article
|
Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.
|
Academic Article
|
Obesity and Subtypes of Incident Cardiovascular Disease.
|
Academic Article
|
Practice-Level Variation in?Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry.
|
Academic Article
|
Severe Hypoglycemia and Elevated High-Sensitivity Cardiac Troponin T in Older Adults With Diabetes: The ARIC Study.
|
Academic Article
|
Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies.
|
Academic Article
|
US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
|
Academic Article
|
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease.
|
Academic Article
|
Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.
|
Academic Article
|
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies.
|
Academic Article
|
Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome.
|
Academic Article
|
Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.
|
Academic Article
|
Calf muscle perfusion as measured with magnetic resonance imaging to assess peripheral arterial disease.
|
Academic Article
|
Magnetic Resonance Venous Volume Measurements in Peripheral Artery Disease (from ELIMIT).
|
Academic Article
|
25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act.
|
Academic Article
|
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
|
Academic Article
|
On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).
|
Academic Article
|
Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials).
|
Academic Article
|
Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
|
Academic Article
|
Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.
|
Academic Article
|
Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.
|
Academic Article
|
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.
|
Academic Article
|
High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Postprandial Monocyte Activation in Individuals With Metabolic Syndrome.
|
Academic Article
|
Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein.
|
Academic Article
|
BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
|
Academic Article
|
Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
|
Academic Article
|
Looking Back at Look AHEAD Through the Lens of Recent Diabetes Outcome Trials.
|
Academic Article
|
Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial.
|
Academic Article
|
Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.
|
Academic Article
|
Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial.
|
Academic Article
|
Serum vitamin D and change in lipid levels over 5?y: The Atherosclerosis Risk in Communities study.
|
Academic Article
|
The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
|
Academic Article
|
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
|
Academic Article
|
Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis Initiative.
|
Academic Article
|
A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
|
Academic Article
|
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
|
Academic Article
|
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs.
|
Academic Article
|
Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.
|
Academic Article
|
Physical Activity, Obesity, and Subclinical?Myocardial Damage.
|
Academic Article
|
Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Weight History and Subclinical Myocardial Damage.
|
Academic Article
|
Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC).
|
Academic Article
|
Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.
|
Academic Article
|
Short-Term Global Cardiovascular Disease Risk?Prediction in Older Adults.
|
Academic Article
|
Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care.
|
Academic Article
|
SES, Heart Failure, and N-terminal Pro-b-type Natriuretic Peptide: The Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.
|
Academic Article
|
Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: ARIC Study.
|
Academic Article
|
Usefulness of Lipoprotein-Associated Phospholipase A2 Activity and C-Reactive Protein in Identifying High-Risk Smokers for Atherosclerotic Cardiovascular Disease (from the Atherosclerosis Risk in Communities Study).
|
Academic Article
|
Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.
|
Academic Article
|
Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study.
|
Academic Article
|
Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
|
Academic Article
|
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
|
Academic Article
|
Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial.
|
Academic Article
|
Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH? patient registry.
|
Academic Article
|
Improving Outcomes After Myocardial Infarction in the US Population.
|
Academic Article
|
Association of lipoprotein-associated phospholipase A2 and risk of incident atrial fibrillation: Findings from 3 cohorts.
|
Academic Article
|
Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.
|
Academic Article
|
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.
|
Academic Article
|
Relation of Lifestyle Factors and Life's Simple 7 Score to Temporal Reduction in Troponin Levels Measured by a High-Sensitivity Assay (from the Atherosclerosis Risk in Communities Study).
|
Academic Article
|
Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.
|
Academic Article
|
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study.
|
Academic Article
|
Effect of Evolocumab on Coronary?Plaque Composition.
|
Academic Article
|
Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry.
|
Academic Article
|
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.
|
Academic Article
|
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial.
|
Academic Article
|
Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse.
|
Academic Article
|
Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease.
|
Academic Article
|
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
|
Academic Article
|
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
|
Academic Article
|
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.
|
Academic Article
|
Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia.
|
Academic Article
|
Sleep apnea and galectin-3: possible sex-specific relationship.
|
Academic Article
|
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders.
|
Academic Article
|
Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study.
|
Academic Article
|
Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease.
|
Academic Article
|
Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.
|
Grant
|
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease
|
Academic Article
|
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
|
Academic Article
|
Multiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions.
|
Academic Article
|
Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids.
|
Academic Article
|
Cancer Survivorship and Subclinical Myocardial Damage.
|
Academic Article
|
Effects of Icosapent Ethyl on Total?Ischemic Events: From REDUCE-IT.
|
Academic Article
|
ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change.
|
Academic Article
|
High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
|
Academic Article
|
Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Metabolomic Pattern Predicts Incident Coronary Heart Disease.
|
Academic Article
|
Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
|
Academic Article
|
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System.
|
Academic Article
|
Statin use in carnitine palmitoyltransferase II deficiency.
|
Academic Article
|
Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study).
|
Academic Article
|
Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides.
|
Academic Article
|
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.
|
Academic Article
|
High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.
|
Academic Article
|
Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction.
|
Academic Article
|
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17?180 Individuals.
|
Academic Article
|
Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults.
|
Academic Article
|
Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.
|
Academic Article
|
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs.
|
Academic Article
|
"Zero": The New Superhero or Superhero in Training?
|
Academic Article
|
Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
|
Academic Article
|
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
|
Academic Article
|
Multi-ancestry sleep-by-SNP interaction analysis in 126,926 individuals reveals lipid loci stratified by sleep duration.
|
Academic Article
|
Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States.
|
Academic Article
|
Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis.
|
Academic Article
|
Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes.
|
Academic Article
|
Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System).
|
Academic Article
|
Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial.
|
Academic Article
|
Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study.
|
Academic Article
|
Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes.
|
Academic Article
|
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease.
|
Academic Article
|
Performance of High-Sensitivity Cardiac Troponin Assays to Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes.
|
Academic Article
|
Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Temporal Trends in E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016 to 2018.
|
Academic Article
|
Physical Activity and Incident Heart Failure in High-Risk Subgroups: The ARIC Study.
|
Academic Article
|
Age-Stratified Sex Disparities in Care and Outcomes in Patients With ST-Elevation Myocardial Infarction.
|
Academic Article
|
Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.
|
Academic Article
|
Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study.
|
Academic Article
|
Autoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: An Analysis From the VITAL Registry.
|
Academic Article
|
Combining Biomarkers and Imaging for Short-Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults.
|
Academic Article
|
Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease: The ARIC Study.
|
Academic Article
|
Sex Hormones and Incident Heart Failure in Men and Postmenopausal Women: The Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women.
|
Academic Article
|
High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes.
|
Academic Article
|
Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk.
|
Academic Article
|
Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity: A Pooled Cohort Analysis.
|
Academic Article
|
Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease.
|
Academic Article
|
Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD.
|
Academic Article
|
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System.
|
Academic Article
|
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials.
|
Academic Article
|
Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects.
|
Academic Article
|
Relation of Magnetic Resonance Imaging Based Arterial Signal Enhancement to Markers of Peripheral Artery Disease.
|
Academic Article
|
Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events: The ARIC Carotid Magnetic Resonance Imaging Study.
|
Academic Article
|
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
|
Academic Article
|
High-Sensitivity Cardiac Troponin I for Risk Stratification in Older Adults.
|
Academic Article
|
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
|
Academic Article
|
High-sensitivity cardiac troponin T and the risk of heart failure in postmenopausal women of the ARIC Study.
|
Academic Article
|
Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.
|
Academic Article
|
Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease.
|
Academic Article
|
Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.
|
Academic Article
|
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study).
|
Academic Article
|
Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Recreational substance use among patients with premature atherosclerotic cardiovascular disease.
|
Academic Article
|
Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease.
|
Academic Article
|
Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis.
|
Academic Article
|
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
|
Academic Article
|
Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia.
|
Academic Article
|
High Burden of Subclinical and Cardiovascular Disease Risk in Adults With Metabolically Healthy Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
|
Academic Article
|
Supplemental Association of Clonal Hematopoiesis With Incident Heart?Failure.
|
Academic Article
|
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.
|
Academic Article
|
Duration of Diabetes and Incident?Heart?Failure: The ARIC (Atherosclerosis Risk In Communities) Study.
|
Academic Article
|
Association between circulating Galectin-3 and arterial stiffness in older adults.
|
Academic Article
|
What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry.
|
Academic Article
|
Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network.
|
Academic Article
|
Association of Longitudinal Changes in Cardiac Biomarkers With Atrial and Ventricular Arrhythmias (from the Atherosclerosis Risk in Communities [ARIC] Study).
|
Academic Article
|
Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
|
Academic Article
|
Technology-Assisted Self-Selection of Candidates for Nonprescription Statin?Therapy.
|
Academic Article
|
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
|
Academic Article
|
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system.
|
Academic Article
|
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
|
Academic Article
|
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
|
Academic Article
|
The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community.
|
Academic Article
|
Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study).
|
Academic Article
|
Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification.
|
Academic Article
|
Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis.
|
Academic Article
|
A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study.
|
Academic Article
|
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment.
|
Academic Article
|
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT.
|
Academic Article
|
Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study.
|
Academic Article
|
Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study.
|
Academic Article
|
Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study.
|
Academic Article
|
Diabetes Duration and Subclinical Myocardial Injury: The Atherosclerosis Risk in Communities Study (ARIC).
|
Academic Article
|
Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report).
|
Academic Article
|
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis.
|
Academic Article
|
Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling project.
|
Academic Article
|
Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death.
|
Academic Article
|
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616.
|
Academic Article
|
Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study.
|
Academic Article
|
Lipid-Lowering Therapy in the Elderly: Are Current Guidelines a Sign of Ageism in Medical Care?
|
Academic Article
|
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.
|
Academic Article
|
Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study.
|
Academic Article
|
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.
|
Academic Article
|
Factors Associated With Circulating Sex Hormones in Men : Individual Participant Data Meta-analyses.
|
Academic Article
|
MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study.
|
Academic Article
|
Social Vulnerability and Cardiovascular-Related Mortality Among Older Adults in the United States.
|
Academic Article
|
Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events.
|
Academic Article
|
Clonal Hematopoiesis Risk Score and All-Cause and Cardiovascular Mortality in Older Adults.
|
Academic Article
|
Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol.
|
Academic Article
|
Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis.
|
Academic Article
|
Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study.
|